COVID Impact (Pharma Supply Chain)
Current situation in a nutshell (Based on my discussion with Industry participants): Relevance of China in India Pharma context: 2/3rd of API and KSM are imported from China (Over the years, share has gone up by 4-5% YoY) Therapies where China holds Leadership (in return commands pricing movement) Vitamins Steroids Antibiotics For the bulk commodity … More COVID Impact (Pharma Supply Chain)